Weans Pharmaceuticals Private Limited - Board Members
Founded in 2023 and headquartered in Kerala, India.
2023 Thrissur, Kerala (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bavish Kadalassery Sudharaj Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Laxmikant Pani Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Nellikaparambil Krishnakumar Vipin Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Parappurath Rajan Vishnuraj Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Sidharth Ram Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Thekkumuri Parambil Sreejith Appointed as Director since June 2023 | Director | 12-Jun-2023 | Current |
Payyappatt Gopi Manju Appointed as Individual Subscriber since June 2023 | Individual Subscriber | 12-Jun-2023 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Weans Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Weans Pharmaceuticals Private Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Weans Pharmaceuticals Private Limited through their registered address at F2, Karthika Block Capitalgalaxy, Lenin Nagar, Punkunnu Thrissur, Thrissur Kerala, 680002, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Weans Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- SIDHARTH RAM
- PAYYAPPATT GOPI MANJU
- BAVISH KADALASSERY SUDHARAJ
- LAXMIKANT PANI
- PARAPPURATH RAJAN VISHNURAJ
- NELLIKAPARAMBIL KRISHNAKUMAR VIPIN
- THEKKUMURI PARAMBIL SREEJITH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.